These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8254389

  • 1. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J.
    J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
    [Abstract] [Full Text] [Related]

  • 2. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, Teräs M, Haaparanta M, Wegelius U, Haapanen A.
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P.
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [Abstract] [Full Text] [Related]

  • 4. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ, Saraste M, Nuutila P, Härkönen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM.
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [Abstract] [Full Text] [Related]

  • 5. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
    de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A.
    Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
    [Abstract] [Full Text] [Related]

  • 6. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P.
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [Abstract] [Full Text] [Related]

  • 7. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM, van Lingen A, Teule GJ, Vaalburg W, Lie KI, Visser CA.
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [Abstract] [Full Text] [Related]

  • 8. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J, Altehoefer C, Büchin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schöndube F, Messmer BJ, Büll U, Hanrath P.
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [Abstract] [Full Text] [Related]

  • 9. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H.
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [Abstract] [Full Text] [Related]

  • 10. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G, Paolini G, Landoni C, Zuccari M, Paganelli G, Galli L, Di Credico G, Vanoli G, Rossetti C, Mariani MA.
    Eur J Nucl Med; 1992 Feb; 19(10):874-81. PubMed ID: 1451704
    [Abstract] [Full Text] [Related]

  • 11. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I, Nitzsche EU, Mix M, Schindler T, Hentschel M, Högerle S, Moser E.
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [Abstract] [Full Text] [Related]

  • 12. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS.
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [Abstract] [Full Text] [Related]

  • 13. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
    Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME.
    J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
    [Abstract] [Full Text] [Related]

  • 14. Simplified PET quantitation of myocardial glucose utilization.
    Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, Shikama N, Himi T, Yoshida K, Masuda Y.
    J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPET.
    Schulz G, von Dahl J, Kaiser HJ, Koch KC, Sabri O, Banneitz L, Cremerius U, Buell U.
    Nucl Med Commun; 1996 Dec; 17(12):1057-64. PubMed ID: 9004303
    [Abstract] [Full Text] [Related]

  • 17. Delineation of myocardial viability with PET.
    Grandin C, Wijns W, Melin JA, Bol A, Robert AR, Heyndrickx GR, Michel C, Vanoverschelde JL.
    J Nucl Med; 1995 Sep; 36(9):1543-52. PubMed ID: 7658208
    [Abstract] [Full Text] [Related]

  • 18. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Liu Q, Zhao S, Yan C, Lu M, Jiang S, Zhang Y, Li S, Liu Y, Yang M, He Z.
    Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
    [Abstract] [Full Text] [Related]

  • 19. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N, Yonekura Y, Kawamoto M, Magata Y, Sasayama S, Takahashi N, Nohara R, Kambara H, Kawai C, Konishi J.
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [Abstract] [Full Text] [Related]

  • 20. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C, Langwieser N, Souvatzoglou M, Batrice A, van Marwick S, Snajberk J, Ibrahim T, Laugwitz KL, Nekolla SG, Schwaiger M.
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.